Arotech Company Profile (NASDAQ:ARTX)

About Arotech (NASDAQ:ARTX)

Arotech logoArotech Corporation is a defense and security products and services company, engaged in providing interactive simulation for military, law enforcement and commercial markets, and batteries and charging systems for the military, commercial and medical markets. The Company operates through two segments: Training and Simulation Division, and Power Systems Division. The Company's Training and Simulation Division develops, manufactures and markets multimedia and interactive digital solutions for engineering, use-of-force training and operator training of military, law enforcement, security, emergency services and other personnel. The Company's Power Systems Division provides battery solutions, energy management and power distribution technologies and product design and manufacturing services for the aerospace, defense, law enforcement, homeland security markets, and it manufactures and sells rechargeable batteries for defense and security products and medical and industrial applications.

Industry, Sector and Symbol:
  • Sector: Aerospace
  • Industry: Industrial Electrical Equipment
  • Sub-Industry: N/A
  • Symbol: NASDAQ:ARTX
  • CUSIP: N/A
  • Web:
  • Market Cap: $86.95 million
  • Outstanding Shares: 25,955,000
Average Prices:
  • 50 Day Moving Avg: $3.16
  • 200 Day Moving Avg: $3.58
  • 52 Week Range: $2.25 - $5.00
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 30.45
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $89.92 million
  • Price / Sales: 0.97
  • Book Value: $2.51 per share
  • Price / Book: 1.33
  • EBIDTA: $5.36 million
  • Net Margins: -0.41%
  • Return on Equity: 3.57%
  • Return on Assets: 2.06%
  • Debt-to-Equity Ratio: 0.14%
  • Current Ratio: 2.11%
  • Quick Ratio: 1.68%
  • Average Volume: 401,409 shs.
  • Beta: 1.44
  • Short Ratio: 0.85

Frequently Asked Questions for Arotech (NASDAQ:ARTX)

What is Arotech's stock symbol?

Arotech trades on the NASDAQ under the ticker symbol "ARTX."

How were Arotech's earnings last quarter?

Arotech Co. (NASDAQ:ARTX) announced its earnings results on Monday, May, 8th. The company reported $0.01 earnings per share for the quarter, hitting analysts' consensus estimates of $0.01. The business earned $22.35 million during the quarter, compared to the consensus estimate of $22.56 million. Arotech had a negative net margin of 0.41% and a positive return on equity of 3.57%. View Arotech's Earnings History.

Where is Arotech's stock going? Where will Arotech's stock price be in 2017?

3 brokerages have issued 1-year target prices for Arotech's shares. Their predictions range from $4.50 to $5.00. On average, they expect Arotech's stock price to reach $4.75 in the next twelve months. View Analyst Ratings for Arotech.

Are investors shorting Arotech?

Arotech saw a increase in short interest in the month of April. As of April 28th, there was short interest totalling 982,713 shares, an increase of 20.9% from the April 13th total of 813,063 shares. Based on an average daily trading volume, of 209,290 shares, the days-to-cover ratio is presently 4.7 days.

Who are some of Arotech's key competitors?

Who are Arotech's key executives?

Arotech's management team includes the folowing people:

  • Jon B. Kutler, Independent Chairman of the Board
  • Dean M Krutty, Acting Chief Executive Officer
  • Thomas J. Paup, Chief Financial Officer, Senior Vice President - Finance
  • Robert S. Ehrlich, Lead Independent Director
  • Lawrence F. Hagenbuch, Director
  • James J. Quinn, Director
  • Michael E. Marrus, Independent Director

Who owns Arotech stock?

Arotech's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Cannell Capital LLC (0.00%), Dimensional Fund Advisors LP (0.00%), Vanguard Group Inc. (0.00%), Renaissance Technologies LLC (0.00%), Essex Investment Management Co. LLC (1.24%) and Acadian Asset Management LLC (0.68%). Company insiders that own Arotech stock include Jon B Kutler, Kenneth W Cappell, Lawrence F Hagenbuch and Robert S Ehrlich. View Institutional Ownership Trends for Arotech.

Who sold Arotech stock? Who is selling Arotech stock?

Arotech's stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC and Alambic Investment Management L.P.. View Insider Buying and Selling for Arotech.

Who bought Arotech stock? Who is buying Arotech stock?

Arotech's stock was bought by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, Cannell Capital LLC, Acadian Asset Management LLC, Essex Investment Management Co. LLC, Credit Agricole S A, Goldman Sachs Group Inc., Morgan Stanley and Geode Capital Management LLC. Company insiders that have bought Arotech stock in the last two years include Jon B Kutler, Kenneth W Cappell and Lawrence F Hagenbuch. View Insider Buying and Selling for Arotech.

How do I buy Arotech stock?

Shares of Arotech can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Arotech's stock price today?

One share of Arotech stock can currently be purchased for approximately $3.35.

MarketBeat Community Rating for Arotech (NASDAQ ARTX)
Community Ranking:  3.0 out of 5 (  )
Outperform Votes:  99 (Vote Outperform)
Underperform Votes:  67 (Vote Underperform)
Total Votes:  166
MarketBeat's community ratings are surveys of what our community members think about Arotech and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Arotech (NASDAQ:ARTX) (?)
Ratings Breakdown: 1 Hold Rating, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $4.75 (41.79% upside)

Analysts' Ratings History for Arotech (NASDAQ:ARTX)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/17/2017ValuEngineUpgradeSell -> HoldMediumView Rating Details
5/15/2017B. RileyReiterated RatingBuy$4.50HighView Rating Details
3/3/2017Singular ResearchInitiated CoverageBuy -> Buy$5.00N/AView Rating Details
(Data available from 5/29/2015 forward)


Earnings History for Arotech (NASDAQ:ARTX)
Earnings by Quarter for Arotech (NASDAQ:ARTX)
Earnings History by Quarter for Arotech (NASDAQ:ARTX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/8/2017Q1 2017$0.01$0.01$22.56 million$22.35 millionViewListenView Earnings Details
3/15/2017Q4 2016$0.04$0.01$25.57 million$21.49 millionViewN/AView Earnings Details
11/8/2016Q3($0.01)$0.06$24.00 million$24.30 millionViewN/AView Earnings Details
8/8/2016Q216($0.01)($0.03)$21.60 million$21.80 millionViewN/AView Earnings Details
5/9/2016Q116$0.04$0.03$26.73 million$25.40 millionViewN/AView Earnings Details
3/14/2016Q415($0.01)$0.06$27.70 million$27.40 millionViewN/AView Earnings Details
11/9/2015Q315($0.01)$0.03$24.70 million$23.30 millionViewN/AView Earnings Details
8/10/2015Q215$0.04($0.04)$26.70 million$21.60 millionViewListenView Earnings Details
5/11/2015Q115$0.03$0.03$27.90 million$24.20 millionViewN/AView Earnings Details
3/16/2015Q4 14($0.04)$0.01$29.00 million$28.60 millionViewN/AView Earnings Details
11/10/2014Q3 2014$0.03$0.02$28.20 million$24.78 millionViewN/AView Earnings Details
8/11/2014Q214$0.04$0.09$28.00 million$27.80 millionViewN/AView Earnings Details
5/13/2014Q114$0.01$0.05$21.30 million$22.40 millionViewN/AView Earnings Details
3/31/2014Q413$0.02($0.03)$21.70 million$20.90 millionViewN/AView Earnings Details
11/12/2013Q3$0.02$0.05$21.40 million$23.20 millionViewListenView Earnings Details
8/12/2013Q2 2013$0.09$20.40 million$22.40 millionViewN/AView Earnings Details
5/13/2013Q1 2013$0.03$16.10 million$22.10 millionViewN/AView Earnings Details
11/7/2012Q312$0.03$21.10 million$21.40 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Arotech (NASDAQ:ARTX)
2017 EPS Consensus Estimate: $0.24
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.03$0.03$0.03
Q2 20171$0.05$0.05$0.05
Q3 20171$0.10$0.10$0.10
Q4 20171$0.06$0.06$0.06
(Data provided by Zacks Investment Research)


Dividend History for Arotech (NASDAQ:ARTX)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Arotech (NASDAQ:ARTX)
Insider Ownership Percentage: 17.30%
Institutional Ownership Percentage: 17.24%
Insider Trades by Quarter for Arotech (NASDAQ:ARTX)
Institutional Ownership by Quarter for Arotech (NASDAQ:ARTX)
Insider Trades by Quarter for Arotech (NASDAQ:ARTX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/18/2016Kenneth W. CappellDirectorBuy9,000$3.23$29,070.00View SEC Filing  
11/16/2016Kenneth W. CappellDirectorBuy11,000$3.34$36,740.00View SEC Filing  
11/11/2016Lawrence F. HagenbuchDirectorBuy4,100$3.19$13,079.00View SEC Filing  
8/22/2016Jon B. KutlerChairmanBuy10,000$2.60$26,000.00View SEC Filing  
6/15/2016Kenneth W CappellDirectorBuy3,000$2.83$8,490.00View SEC Filing  
6/7/2016Robert S EhrlichDirectorSell10,000$3.03$30,300.00View SEC Filing  
6/3/2016Jon B KutlerChairmanBuy39,179$2.68$104,999.72View SEC Filing  
3/13/2015Steven D EssesCEOSell20,000$3.00$60,000.00View SEC Filing  
11/13/2014Robert S EhrlichChairmanBuy7,500$2.43$18,225.00View SEC Filing  
11/3/2014Steven D EssesCEOSell5,000$3.08$15,400.00View SEC Filing  
10/3/2014Robert S EhrlichChairmanSell8,800$3.33$29,304.00View SEC Filing  
10/1/2014Robert S EhrlichChairmanSell1,200$3.27$3,924.00View SEC Filing  
10/1/2014Steven D EssesCEOSell5,000$3.20$16,000.00View SEC Filing  
9/10/2014Steven D EssesPresidentSell5,000$3.86$19,300.00View SEC Filing  
9/2/2014Robert S EhrlichCEOSell8,500$3.65$31,025.00View SEC Filing  
7/1/2014Robert S EhrlichCEOSell8,500$4.46$37,910.00View SEC Filing  
7/1/2014Steven D EssesPresidentSell3,000$4.46$13,380.00View SEC Filing  
7/1/2014Thomas J PaupCFOSell15,000$4.46$66,900.00View SEC Filing  
6/2/2014Robert S EhrlichCEOSell8,500$4.20$35,700.00View SEC Filing  
6/2/2014Steven D EssesPresidentSell3,000$4.20$12,600.00View SEC Filing  
4/24/2014Elliot SloyerDirectorBuy50,000$3.57$178,500.00View SEC Filing  
4/1/2014Robert S EhrlichCEOSell8,500$5.53$47,005.00View SEC Filing  
4/1/2014Steven D EssesPresidentSell3,000$5.53$16,590.00View SEC Filing  
12/5/2013Robert S EhrlichCEOSell100,000$2.45$245,000.00View SEC Filing  
12/3/2013Steven D EssesPresidentSell65,000$2.43$157,950.00View SEC Filing  
11/29/2012Elliot SloyerDirectorBuy10,000$1.07$10,700.00View SEC Filing  
11/16/2012Elliot SloyerDirectorBuy3,169$1.00$3,169.00View SEC Filing  
9/12/2012Elliot SloyerDirectorBuy11,949$0.82$9,798.18View SEC Filing  
8/31/2012Elliot SloyerDirectorBuy9,730$0.81$7,881.30View SEC Filing  
8/30/2012Elliot SloyerDirectorBuy14,426$0.79$11,396.54View SEC Filing  
8/28/2012Elliot SloyerDirectorBuy7,580$0.78$5,912.40View SEC Filing  
8/24/2012Elliot SloyerDirectorBuy16,644$0.80$13,315.20View SEC Filing  
8/14/2012Elliot SloyerDirectorBuy24,937$0.74$18,453.38View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Arotech (NASDAQ:ARTX)
Latest Headlines for Arotech (NASDAQ:ARTX)
DateHeadline logoArotech Co. (ARTX) Cut to "Hold" at Zacks Investment Research - May 26 at 8:42 PM logoTop 5 Technology Penny Stocks to Watch - May 23 at 9:03 AM logoArotech Co. (ARTX) Short Interest Up 20.9% in April - May 18 at 4:22 PM logoArotech Co. (ARTX) Stock Rating Upgraded by ValuEngine - May 17 at 4:38 PM logoArotech Co. (ARTX) Receives "Buy" Rating from B. Riley - May 15 at 7:34 PM logoArotech's (ARTX) CEO Steven Esses on Q1 2017 Results - Earnings Call Transcript - Seeking Alpha - May 13 at 2:15 AM logoQ3 2017 Earnings Estimate for Arotech Co. Issued By B. Riley (ARTX) - May 12 at 11:45 AM logoEdited Transcript of ARTX earnings conference call or presentation 9-May-17 1:00pm GMT - May 11 at 9:09 PM logoB. Riley Reaffirms "Buy" Rating for Arotech Co. (ARTX) - May 10 at 9:30 PM logoArotech Co. (ARTX) Issues Quarterly Earnings Results - May 9 at 10:22 AM logoArotech Reports First Quarter 2017 Results - May 8 at 8:36 PM logoArotech reports 1Q loss - May 8 at 5:36 PM logoLatest Developments in Battery Technology to Be Presented at Seminars in Milan and Rome this Month - May 8 at 3:34 PM logoArotech Co. (ARTX) to Release Quarterly Earnings on Monday - May 6 at 12:16 AM logoArotech Co. (ARTX) Set to Announce Earnings on Monday - May 5 at 11:31 PM logoArotech Co. (ARTX) Receives Buy Rating from B. Riley - May 5 at 7:54 AM logoPositive Media Coverage Extremely Likely to Impact Arotech (ARTX) Share Price - May 2 at 1:32 PM logoETFs with exposure to Arotech Corp. : May 1, 2017 - May 2 at 8:46 AM logoArotech to Release First Quarter 2017 Results on Monday, May 8, 2017 - May 2 at 8:46 AM logoArotech (ARTX) Getting Favorable Press Coverage, AlphaOne Reports - April 20 at 8:29 AM logoETFs with exposure to Arotech Corp. : April 19, 2017 - April 19 at 3:41 PM logoArotech (ARTX) Earning Very Positive Media Coverage, Analysis Shows - April 17 at 10:23 AM logoSomewhat Positive Media Coverage Very Likely to Effect Arotech (ARTX) Share Price - April 14 at 5:21 PM logoETFs with exposure to Arotech Corp. : April 7, 2017 - April 7 at 8:41 PM logoArotech’s FAAC Incorporated Receives $41.1 M Follow-On Contract for U.S. Army’s Virtual Clearance Training Suite - April 3 at 4:00 PM logoArotech Co. (ARTX) Upgraded to "Strong-Buy" at Zacks Investment Research - March 28 at 10:04 AM logoArotech Co. (ARTX) Upgraded at Zacks Investment Research - March 22 at 8:34 PM logoAROTECH CORP Financials - March 22 at 4:08 PM logoBrokerages Expect Arotech Co. (ARTX) to Announce ($0.02) Earnings Per Share - March 21 at 10:52 AM logo8:22 am Arotech receives a sole source $9.5 mln IDIQ award from the U.S. Air Force; the contract period of performance is through March 2022 and two task orders were issued upon award valued at $2.32 mln - March 20 at 3:57 PM logoArotech Training and Simulation Receives $9.5M U.S. Air Force IDIQ Award With Initial Task Orders Valued at $2.32M - March 20 at 8:34 AM logoAROTECH CORP Files SEC form 10-K, Annual Report - March 16 at 5:07 PM logoArotech Co. (ARTX) Issues Quarterly Earnings Results, Misses Estimates By $0.03 EPS - March 16 at 10:43 AM logoArotech Reports Fourth Quarter and Full Year 2016 results - March 15 at 8:53 PM logoAROTECH CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits - March 15 at 8:53 PM logoQ4 2016 Arotech Corp Earnings Release - After Market Close - March 15 at 3:52 PM logoArotech's U.S. Power Systems Division Announces $8.3M in Awards ... - GlobeNewswire (press release) - March 7 at 8:29 AM logoArotech to Release Fourth Quarter and Year End 2016 Results on Wednesday, March 15, 2017 - March 7 at 8:29 AM logoArotech’s U.S. Power Systems Division Announces $8.3M in Awards - March 6 at 11:07 AM logo8:23 am Arotech received contract awards from both government and commercial customers totaling $8.3 million over the last three weeks - March 6 at 11:07 AM logoCoverage initiated on Arotech by Singular Research - March 3 at 8:53 PM logoAROTECH CORP Files SEC form 8-K, Change in Directors or Principal Officers - February 8 at 3:51 PM logoMonday Sector Laggards: Oil & Gas Exploration & Production, Defense Stocks - January 24 at 1:43 AM logoArotech (ARTX) Shares March Higher, Can It Continue? - January 9 at 3:54 PM logoL3 Technologies Acquires ETD Assets of Implant Sciences - January 6 at 3:45 PM logoBull of the Day: Arotech Corp (ARTX) - January 5 at 1:47 AM logoArotech, Cooper Companies, UnitedHealth Group, Aetna and Humana highlighted as Zacks Bull and Bear of the Day - January 4 at 3:45 PM logoArotech Corp. (ARTX) Announces Early Termination of CEO, Steven Esses - January 4 at 2:40 AM logoAROTECH CORP Files SEC form 8-K, Entry into a Material Definitive Agreement - January 4 at 2:40 AM logoCEO Steven Esses out at Arotech - Seeking Alpha - January 3 at 9:18 PM



Arotech (ARTX) Chart for Monday, May, 29, 2017

This page was last updated on 5/29/2017 by Staff